Results: Out of 42 cases, CD99 and FLI-1 expressions were observed in 14 (33.3 %) and 7 (16.7 %) tumors, respectively. Concomittant expressions of CD99 and FLI-1 proteins were found in 5/42 (11.9 %) cases.